Skip to main content
. 2013 Jul 19;3:2233. doi: 10.1038/srep02233

Figure 6. Safety profiles of PVAX.

Figure 6

(a) Creatinine and ALT level after daily i.p. administration of PVAX (100 μg/day) for 7 days. NS = not significant. N = 4/group. (b) Representative Hematoxylin and Eosin (H&E)-stained tissue sections of various organs after PVAX. PVAX was administered i.p. at 100 mg/day for 7 days. N = 3/group.